MedPath

Living a Pregnancy After a Peri-natal Grief: How Well Does Pregnancy Follow-up Meet Women's Needs and Expectations?

Not Applicable
Completed
Conditions
Pregnancy Related
Registration Number
NCT06107530
Lead Sponsor
Fondation Hôpital Saint-Joseph
Brief Summary

Every year in France, around 7,000 children are born without life, following a medical termination of pregnancy (IMG), fetal death in utero (FDIU) or premature delivery ("late miscarriage"). For families affected by perinatal bereavement, the pregnancy that follows this silent birth is a moment apart, between anguish and guilt, joy and apprehension. The aim of this research project is to improve the understanding of what women go through during the pregnancy that follows, with a view to proposing a practical tool for the professionals who take care of them, in order to improve and personalize their follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
9
Inclusion Criteria
  • Women who have given birth to a stillborn child (singleton or twin pregnancies):

    • delivery following fetal death in utero or medical termination of pregnancy at 15 weeks gestational age and later
    • extreme preterm birth ("late miscarriage") from 15 weeks gestational age Patient who subsequently carried a pregnancy to term and gave birth to a live, viable child between 2020 and 2023.
  • French-speaking patient

  • Patient who does not object to her participation in this research study

Exclusion Criteria
  • Women who have experienced a natural termination of pregnancy ("early miscarriage") before 15 weeks of amenorrhea.
  • Women who have given birth by suction in the operating theatre.
  • Women who are pregnant with twins in the pregnancy following bereavement. Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under court protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Identify women's specific needs and expectations for the follow-up of this particular pregnancy4months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondation hôpital Saint Joseph

🇫🇷

Paris, France

Fondation hôpital Saint Joseph
🇫🇷Paris, France
Hélène BEAUSSIER, pharmaD, phD
Contact
+144127038
hbeaussier@ghpsj.fr
Juliette COURTIADE MAHLER, phD
Contact
++144127963
jcourtiade@ghpsj.fr
Anne Charlotte LAURENT, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.